Modulating Inhibitory Control Networks in Gambling Disorder With Theta Burst Stimulation
Recruiting
Phase 3
Interventional Study
Gambling Disorder
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Pivotal Trial
This treatment is in the last trial phase before FDA approval.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 – 65
- Sex
- Any
- Trial phase
- Phase 3
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 40 (estimated)
- Sponsor
- CNS Onlus · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
In this project the investigators propose a randomized double-blind placebo-controlled design in which 40 patients with GD will receive active or sham cTBS to the pre-SMA for 2 weeks. The investigators will combine TMS, multimodal structural and functional MRI and behavioral measures in order to identify circuit-level mechanisms of action and therapeutic targets (connectivity changes that explain …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. DSM-5 diagnosis of Gambling Disorder
2. Age between 18 and 65 years
Exclusion Criteria:
1. any additional current psychiatric comorbidity, except for nicotine addiction;
2. a lifetime DSM-5 diagnosis of schizophrenia or other psychotic syndromes, substance dependence or sub…
Contacts
No contact information available.